Display options
Cite
Warr WA. A CADD-alog of strategies in pharma. J Comput Aided Mol Des. 2017;31(3):245-247doi: 10.1007/s10822-017-0017-6.
Warr, W. A. (2017). A CADD-alog of strategies in pharma. Journal of computer-aided molecular design, 31(3), 245-247. https://doi.org/10.1007/s10822-017-0017-6
Warr, Wendy A. "A CADD-alog of strategies in pharma." Journal of computer-aided molecular design vol. 31,3 (2017): 245-247. doi: https://doi.org/10.1007/s10822-017-0017-6
Warr WA. A CADD-alog of strategies in pharma. J Comput Aided Mol Des. 2017 Mar;31(3):245-247. doi: 10.1007/s10822-017-0017-6. Epub 2017 Mar 18. PMID: 28315993.
Copy Download .nbib Format: NLM
Share it on

J Comput Aided Mol Des. 2017 Mar;31(3):245-247. doi: 10.1007/s10822-017-0017-6. Epub 2017 Mar 18.

A CADD-alog of strategies in pharma.

Journal of computer-aided molecular design

Wendy A Warr

Affiliations

  1. Wendy Warr & Associates, Holmes Chapel, Crewe, Cheshire, UK. [email protected].

PMID: 28315993 DOI: 10.1007/s10822-017-0017-6

Abstract

A special issue on computer-aided drug design (CADD) strategies in pharma discusses how CADD groups in different environments work. Perspectives were collected from authors in 11 organizations: four big pharmaceutical companies, one major biotechnology company, one smaller biotech, one private pharmaceutical company, two contract research organizations (CROs), one university, and one that spans the breadth of big pharmaceutical companies and one smaller biotech.

MeSH terms

Publication Types